We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. Drug Facility Inspections See Drop in Significant Violation Findings
U.S. Drug Facility Inspections See Drop in Significant Violation Findings
Inspections of U.S. pharmaceutical manufacturing facilities have seen a declining number of official warnings over the past five years, but the trend is less clear on the international front.